$IGXT #OTCQX U.S. IntelGenx Technologies Corp. (IGXT: OTCQX U.S.) | IntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a Trial
Copyright 2019 – OTC Markets Group Inc.

News Link